RS Research Revenue and Competitors
Estimated Revenue & Valuation
- RS Research's estimated annual revenue is currently $1.6M per year.
- RS Research's estimated revenue per employee is $71,400
Employee Data
- RS Research has 23 Employees.
- RS Research grew their employee count by 5% last year.
RS Research's People
Name | Title | Email/Phone |
---|
RS Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13M | 127 | 43% | N/A | N/A |
#2 | $11.2M | 110 | 62% | N/A | N/A |
#3 | $27.3M | 243 | 10% | N/A | N/A |
#4 | $26M | 237 | 25% | $11M | N/A |
#5 | $3.3M | 41 | -11% | N/A | N/A |
#6 | $11.6M | 114 | 24% | N/A | N/A |
#7 | $1.6M | 22 | 5% | N/A | N/A |
#8 | $34.9M | 548 | 18% | N/A | N/A |
#9 | $50.2M | 394 | -5% | N/A | N/A |
#10 | $13.6M | 243 | -10% | N/A | N/A |
What Is RS Research?
RS Research is a clinical-stage biotechnology start-up developing next generation nanomedicines based on innovative drug delivery platform Sagitta® for targeted chemotherapy. We currently have 5 drug candidates, with different indications in oncology. The most advanced one has completed pre-clinical phase and achieved IND approval to launch Phase-I clinical trials early 2021. The company, founded in 2015, raised a total of 2 million Euro in 2017, from ACT VC.
keywords:N/AN/A
Total Funding
23
Number of Employees
$1.6M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RS Research News
Commenting on Tuesday's market trend, Rahul Sharma, Research Head, Equity 99 said, "We witnessed mayhem in markets in last 30 minutes.
The details of the examinations are published on the website http://dccc.iisc.ac.in. The scholarship programme with prizes worth Rs 50 lakhs for...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.8M | 23 | -32% | N/A |
#2 | $4.7M | 23 | 0% | N/A |
#3 | $2.3M | 23 | N/A | N/A |
#4 | $1.7M | 23 | N/A | N/A |
#5 | $2.3M | 23 | N/A | N/A |